| INBX |
Inhibrx Biosciences, Inc. |
28 May 2025 |
1 |
$0 |
4 |
Director |
29 May 2025, 16:35 |
| INBX |
Inhibrx Biosciences, Inc. |
28 Aug 2024 |
1 |
+$139,800 |
4 |
Director |
30 Aug 2024, 16:16 |
| /report/000095014224001501-manhard-kimberly-2024-05-30 |
Inhibrx, Inc. |
30 May 2024 |
5 |
$0 |
4 |
Director |
30 May 2024, 18:23 |
| INBX |
Inhibrx Biosciences, Inc. |
30 May 2024 |
1 |
$0 |
4 |
Director |
30 May 2024, 18:11 |
| INBX |
Inhibrx Biosciences, Inc. |
24 May 2024 |
0 |
$0 |
3 |
Director |
24 May 2024, 16:48 |
| /report/000173961423000052-manhard-kimberly-2023-05-25 |
Inhibrx, Inc. |
25 May 2023 |
1 |
$0 |
4 |
Director |
30 May 2023, 16:08 |
| HRTX |
HERON THERAPEUTICS, INC. /DE/ |
13 Apr 2023 |
5 |
-$4,081 |
4 |
EVP, Drug Development |
17 Apr 2023, 17:26 |
| HRTX |
HERON THERAPEUTICS, INC. /DE/ |
18 Jan 2023 |
1 |
$0 |
4 |
EVP, Drug Development, Director |
20 Jan 2023, 16:08 |
| HRTX |
HERON THERAPEUTICS, INC. /DE/ |
13 Jan 2023 |
6 |
-$962 |
4 |
EVP, Drug Development, Director |
17 Jan 2023, 16:34 |
| HRTX |
HERON THERAPEUTICS, INC. /DE/ |
13 Oct 2022 |
5 |
-$7,565 |
4 |
EVP, Drug Development, Director |
17 Oct 2022, 16:36 |
| HRTX |
HERON THERAPEUTICS, INC. /DE/ |
25 Jul 2022 |
1 |
$0 |
4 |
EVP, Drug Development, Director |
27 Jul 2022, 18:21 |
| HRTX |
HERON THERAPEUTICS, INC. /DE/ |
13 Jul 2022 |
5 |
-$6,056 |
4 |
EVP, Drug Development, Director |
15 Jul 2022, 16:55 |
| /report/000173961422000061-manhard-kimberly-2022-05-25 |
Inhibrx, Inc. |
25 May 2022 |
1 |
$0 |
4 |
Director |
26 May 2022, 16:31 |
| HRTX |
HERON THERAPEUTICS, INC. /DE/ |
03 May 2022 |
2 |
-$1,375 |
4 |
EVP, Drug Development, Director |
04 May 2022, 19:01 |
| HRTX |
HERON THERAPEUTICS, INC. /DE/ |
13 Apr 2022 |
5 |
-$12,213 |
4 |
EVP, Drug Development, Director |
15 Apr 2022, 17:03 |
| HRTX |
HERON THERAPEUTICS, INC. /DE/ |
13 Jan 2022 |
5 |
-$16,700 |
4 |
EVP, Drug Development, Director |
14 Jan 2022, 16:05 |
| HRTX |
HERON THERAPEUTICS, INC. /DE/ |
13 Oct 2021 |
5 |
-$4,568 |
4 |
EVP, Drug Development, Director |
15 Oct 2021, 16:22 |
| HRTX |
HERON THERAPEUTICS, INC. /DE/ |
13 Jul 2021 |
3 |
-$5,837 |
4 |
EVP, Drug Development, Director |
15 Jul 2021, 16:47 |
| /report/000173961421000070-manhard-kimberly-2021-06-07 |
Inhibrx, Inc. |
07 Jun 2021 |
1 |
$0 |
4 |
Director |
08 Jun 2021, 17:19 |